PEN Q2 2020 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$105M-21.7% YoY

Gross Profit

$65M61.8% margin

Operating Income

-$18M-16.8% margin

Net Income

-$12M-11.4% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-23.5%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$780M

Total Liabilities

$157M

Stockholders' Equity

$625M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$105M	$134M	-21.7%
Gross Profit	$65M	$94M	-30.9%
Operating Income	-$18M	$13M	-237.9%
Net Income	-$12M	$17M	-172.1%

Revenue Segments

Neuro

$59M56%

Peripheral Vascular

$46M44%

Geographic Segments

UNITED STATES

$78M74%

Other Non-US

$27M26%